WEC
48
7
DHI
35
4
YUM
33
-2
MOS
48
-2
PEP
32
2
XEL
51
8
D
53
5
AES
39
-2
ITW
33
2
VRSK
56
16
GME
66
-2
UNP
38
2
NDAQ
50
4
TJX
42
5
STT
59
14
AON
36
4
EXR
37
15
OI
30
-4
AMP
52
6
COF
47
-2
WEC
48
7
DHI
35
4
YUM
33
-2
MOS
48
-2
PEP
32
2
XEL
51
8
D
53
5
AES
39
-2
ITW
33
2
VRSK
56
16
GME
66
-2
UNP
38
2
NDAQ
50
4
TJX
42
5
STT
59
14
AON
36
4
EXR
37
15
OI
30
-4
AMP
52
6
COF
47
-2
Financhill
Back

iShares S&P/TSX Energy Transition Mtrls Idx ETF Vs. Janux Therapeutics Industry Stock Comparison

Sell
30

XETM.TO
iShares S&P/TSX Energy Transition Mtrls Idx ETF

Last Price:
$40.50
Seasonality Move:
-0.26%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
30
iShares S&P/TSX Energy Transition Mtrls Idx ETF (XETM.TO) is a Sell

Is iShares S&P/TSX Energy Transition Mtrls Idx ETF a Buy, Sell or Hold?

  • The current iShares S&P/TSX Energy Transition Mtrls Idx ETF [XETM.TO] share price is $40.50. The Score for XETM.TO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • XETM.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XETM.TO Stock Price Chart

What is iShares S&P/TSX Energy Transition Mtrls Idx ETF's stock price today?

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

XETM.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 28.35 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.14 - 44.12) Sell
Bollinger Bands (100): (38.16 - 44.24) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

XETM.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.7 Sell
20-day SMA: 42.31 Sell
50-day SMA: 43.18 Sell
200-day SMA: 41.76 Sell
8-day EMA: 40.99 Sell
20-day EMA: 41.85 Sell
50-day EMA: 42.36 Sell
200-day EMA: 40.84 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

iShares S&P/TSX Energy Transition Mtrls Idx ETF Earnings Growth & XETM.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

iShares S&P/TSX Energy Transition Mtrls Idx ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):